about
Interventions for prevention of post-operative recurrence of Crohn's diseaseThe frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study.Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive.Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease.Estrogen receptors and their implications in colorectal carcinogenesis.Depth-dependent differences in community structure of the human colonic microbiota in health.Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers.Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potentialComparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's diseaseEnrichment of Inflammatory IL-17 and TNF-α Secreting CD4(+) T Cells within Colorectal Tumors despite the Presence of Elevated CD39(+) T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease PathogenesisGastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation.Hydroxylases as therapeutic targets in inflammatory bowel disease.Evaluation of the small bowel in inflammatory bowel disease.Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease.Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies.Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy.Subclassification of small bowel Crohn's disease using magnetic resonance enterography: a review using evidence-based medicine methodology.Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner.Hypoxia-dependent regulation of inflammatory pathways in immune cellsThe Stressometer: A Simple, Valid, and Responsive Measure of Psychological Stress in Inflammatory Bowel Disease Patients.Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.Prolonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn's disease.A comparative study of short- and medium-term outcomes comparing emergent surgery and stenting as a bridge to surgery in patients with acute malignant colonic obstruction.Inter-endoscopist agreement in diagnosis of Barrett's oesophagus.Body image dissatisfaction: clinical features, and psychosocial disability in inflammatory bowel disease.Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ('Exit Strategies') in Inflammatory Bowel Disease.Awareness of adverse effects of azathioprine in patients with inflammatory bowel disease--more to be done?Expression of COX-2 and prognostic outcome in uveal melanoma.Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.Clinical and pathological factors associated with colorectal cancer at the upper extreme of life.Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population.Management of complex colonic polyps in the English Bowel Cancer Screening Programme (Br j surg 2013; 100: 1633-1639).Mechanism of basic calcium phosphate crystal-stimulated cyclo-oxygenase-1 up-regulation in osteoarthritic synovial fibroblasts.Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2.
P50
Q24240542-7C56D2CC-A776-43C0-BF89-858D6079892CQ31157634-040A19CE-9C6B-45C3-9052-888C10BF8159Q33475171-9E5964B8-A007-4E45-A450-1134EC814043Q34113544-3169D887-2D2A-4E28-B122-D16FCB1FEA4FQ34615496-4A5D6E94-0AF7-4BF0-8B06-B5904CEC5436Q35037282-BEABCB7D-867D-4077-9A3E-BDB0CFC231A8Q35040241-480814E9-E572-46CF-96CF-E9657F49817CQ35544114-32EB138F-8D03-4264-BD59-D5A99E25CEECQ35747359-236730F6-6D0A-4397-B8E0-FE0DFCC40232Q36055027-338275A0-72EB-4B00-96A9-A7EB150A8C1DQ36658129-413DB7DB-720E-40F7-B0CA-63A6F08A614DQ37237816-FFB14C9A-1B55-444A-B2C9-205CF0CAB75FQ37697523-64C5DFBD-4519-4F58-8762-028111A76021Q38082620-A9230A2E-0681-4E02-8D4E-5A08656E4350Q38085064-81823247-58BE-4E1E-B36E-578815FE5F65Q38125275-C0611F76-97A8-4E78-B1F1-00FD010F53E3Q38194708-0ECFFEFB-2C1B-45FB-84F2-6CC1A880FF92Q38390840-BF5201B6-1EFF-4571-B955-E1C637D785DBQ38400172-2C30A8D5-E9C8-49FE-9AFD-108884A15797Q38587212-AA618233-65F7-4C85-9F59-EAF762EA416EQ38774290-16FD03F3-E299-4CFC-AED2-7F4D0EDB9B71Q38907502-41BDC8EB-F4ED-44DB-9A2F-FC85137987E0Q38980010-40547428-7178-4E80-A991-45A028A778E2Q39043418-D3895B34-A758-437E-9FA5-06ECC025FC27Q39064412-9E2FC80D-5475-43EA-8BA7-02EBC241DA07Q39144794-09594BBD-C649-4530-86B1-ACBAE48825D6Q39243380-83F7D244-09D3-40D3-B1AE-E2D3A99F4571Q39453897-ABDE0E67-CB32-4CCD-A333-49C2E81AC58FQ41189177-DEB901D1-D1B8-4EFA-BCFF-F06C2CBF92A9Q41608470-ED62C283-E77D-4350-AB8F-C0D656ED112EQ41985015-6B374D14-1D01-4A06-9E73-85A26B5652F5Q41990807-3EBE229B-A4A2-47E4-B1C7-B06766F62BE3Q42343788-AC347BD7-0ED5-493F-AF40-A38720B78D91Q43648135-C2C13699-68D0-44B4-8ED4-0238D9F1D519Q45927309-0DB097CA-477B-4604-9641-780B2CB2ECA0Q46262450-D7273602-5D94-4F51-9672-CCEE233B807CQ46457907-9585E76B-B645-4BD0-AB0D-4C441302368AQ46612501-E4451DB0-4CCB-4480-B5F2-B74B75918FDFQ46617767-190AE9D5-7874-4E63-8142-9CB2181DEDCCQ46788884-6B9C0698-9177-45DF-9322-021536770243
P50
description
researcher ORCID ID = 0000-0003-4384-5049
@en
wetenschapper
@nl
name
Glen A Doherty
@ast
Glen A Doherty
@en
Glen A Doherty
@nl
type
label
Glen A Doherty
@ast
Glen A Doherty
@en
Glen A Doherty
@nl
prefLabel
Glen A Doherty
@ast
Glen A Doherty
@en
Glen A Doherty
@nl
P31
P496
0000-0003-4384-5049